トランスサイレチンアミロイドーシス（ATTR）の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Transthyretin Amyloidosis (ATTR) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-02858 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、トランスサイレチンアミロイドーシス（ATTR）の世界市場を広く調査・分析し、今後の市場展望をまとめております。トランスサイレチンアミロイドーシス（ATTR）の種類別市場規模（遺伝性ATTR（HATTR）、野生型（WT）ATTR）、用途別市場規模（病院、外来手術センター、診断センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Corino Therapeutics、Alnylam Pharmaceuticals、Ionis Pharmaceuticals、Arcturus Therapeutics、Proclara Bioscience ・地域別グローバル市場分析 2015年-2020年 ・トランスサイレチンアミロイドーシス（ATTR）の北米市場（アメリカ、カナダ、メキシコ） ・トランスサイレチンアミロイドーシス（ATTR）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・トランスサイレチンアミロイドーシス（ATTR）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・トランスサイレチンアミロイドーシス（ATTR）の南米市場（ブラジル、アルゼンチン） ・トランスサイレチンアミロイドーシス（ATTR）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：遺伝性ATTR（HATTR）、野生型（WT）ATTR ・用途別分析：病院、外来手術センター、診断センター ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Transthyretin Amyloidosis (ATTR) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Transthyretin Amyloidosis (ATTR) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Transthyretin Amyloidosis (ATTR) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Transthyretin Amyloidosis (ATTR) market has been segmented into:
Hereditary ATTR (HATTR)
Wild-Type (WT) ATTR

By Application, Transthyretin Amyloidosis (ATTR) has been segmented into:
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Transthyretin Amyloidosis (ATTR) market presented in the report. This section sheds light on the sales growth of different regional and country-level Transthyretin Amyloidosis (ATTR) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Transthyretin Amyloidosis (ATTR) market.

The report offers in-depth assessment of the growth and other aspects of the Transthyretin Amyloidosis (ATTR) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Transthyretin Amyloidosis (ATTR) Market Share Analysis
Transthyretin Amyloidosis (ATTR) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Transthyretin Amyloidosis (ATTR) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Transthyretin Amyloidosis (ATTR) sales, revenue and market share for each player covered in this report.

The major players covered in Transthyretin Amyloidosis (ATTR) are:
Pfizer
Corino Therapeutics
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Arcturus Therapeutics
Proclara Bioscience

レポート目次

---

Table of Contents

1 Transthyretin Amyloidosis (ATTR) Market Overview
1.1 Product Overview and Scope of Transthyretin Amyloidosis (ATTR)
1.2 Classification of Transthyretin Amyloidosis (ATTR) by Type
1.2.1 Global Transthyretin Amyloidosis (ATTR) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Type in 2019
1.2.3 Hereditary ATTR (HATTR)
1.2.4 Wild-Type (WT) ATTR
1.3 Global Transthyretin Amyloidosis (ATTR) Market by Application
1.3.1 Overview: Global Transthyretin Amyloidosis (ATTR) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Global Transthyretin Amyloidosis (ATTR) Market by Regions
1.4.1 Global Transthyretin Amyloidosis (ATTR) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Transthyretin Amyloidosis (ATTR) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Transthyretin Amyloidosis (ATTR) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Transthyretin Amyloidosis (ATTR) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Transthyretin Amyloidosis (ATTR) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Transthyretin Amyloidosis (ATTR) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Transthyretin Amyloidosis (ATTR) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Corino Therapeutics
2.2.1 Corino Therapeutics Details
2.2.2 Corino Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Corino Therapeutics SWOT Analysis
2.2.4 Corino Therapeutics Product and Services
2.2.5 Corino Therapeutics Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Alnylam Pharmaceuticals
2.3.1 Alnylam Pharmaceuticals Details
2.3.2 Alnylam Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Alnylam Pharmaceuticals SWOT Analysis
2.3.4 Alnylam Pharmaceuticals Product and Services
2.3.5 Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Ionis Pharmaceuticals
2.4.1 Ionis Pharmaceuticals Details
2.4.2 Ionis Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Ionis Pharmaceuticals SWOT Analysis
2.4.4 Ionis Pharmaceuticals Product and Services
2.4.5 Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Arcturus Therapeutics
2.5.1 Arcturus Therapeutics Details
2.5.2 Arcturus Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Arcturus Therapeutics SWOT Analysis
2.5.4 Arcturus Therapeutics Product and Services
2.5.5 Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Proclara Bioscience
2.6.1 Proclara Bioscience Details
2.6.2 Proclara Bioscience Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Proclara Bioscience SWOT Analysis
2.6.4 Proclara Bioscience Product and Services
2.6.5 Proclara Bioscience Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Transthyretin Amyloidosis (ATTR) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Transthyretin Amyloidosis (ATTR) Players Market Share
3.2.2 Top 10 Transthyretin Amyloidosis (ATTR) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Transthyretin Amyloidosis (ATTR) Revenue and Market Share by Regions
4.2 North America Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
4.3 Europe Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
4.5 South America Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
5 North America Transthyretin Amyloidosis (ATTR) Revenue by Countries
5.1 North America Transthyretin Amyloidosis (ATTR) Revenue by Countries (2015-2020)
5.2 USA Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
5.3 Canada Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
5.4 Mexico Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
6 Europe Transthyretin Amyloidosis (ATTR) Revenue by Countries
6.1 Europe Transthyretin Amyloidosis (ATTR) Revenue by Countries (2015-2020)
6.2 Germany Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
6.3 UK Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
6.4 France Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
6.5 Russia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
6.6 Italy Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue by Countries
7.1 Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue by Countries (2015-2020)
7.2 China Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
7.3 Japan Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
7.4 Korea Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
7.5 India Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
8 South America Transthyretin Amyloidosis (ATTR) Revenue by Countries
8.1 South America Transthyretin Amyloidosis (ATTR) Revenue by Countries (2015-2020)
8.2 Brazil Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
8.3 Argentina Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Transthyretin Amyloidosis (ATTR) by Countries
9.1 Middle East & Africa Transthyretin Amyloidosis (ATTR) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
9.3 UAE Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
9.4 Egypt Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
9.5 South Africa Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Transthyretin Amyloidosis (ATTR) Revenue and Market Share by Type (2015-2020)
10.2 Global Transthyretin Amyloidosis (ATTR) Market Forecast by Type (2019-2024)
10.3 Hereditary ATTR (HATTR) Revenue Growth Rate (2015-2025)
10.4 Wild-Type (WT) ATTR Revenue Growth Rate (2015-2025)
11 Global Transthyretin Amyloidosis (ATTR) Market Segment by Application
11.1 Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Application (2015-2020)
11.2 Transthyretin Amyloidosis (ATTR) Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.5 Diagnostic Centers Revenue Growth (2015-2020)
12 Global Transthyretin Amyloidosis (ATTR) Market Size Forecast (2021-2025)
12.1 Global Transthyretin Amyloidosis (ATTR) Market Size Forecast (2021-2025)
12.2 Global Transthyretin Amyloidosis (ATTR) Market Forecast by Regions (2021-2025)
12.3 North America Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2021-2025)
12.4 Europe Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2021-2025)
12.6 South America Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Transthyretin Amyloidosis (ATTR) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Transthyretin Amyloidosis (ATTR) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Transthyretin Amyloidosis (ATTR) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Transthyretin Amyloidosis (ATTR) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Transthyretin Amyloidosis (ATTR) Major Business
Table 7. Pfizer Transthyretin Amyloidosis (ATTR) Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Transthyretin Amyloidosis (ATTR) Product and Solutions
Table 10. Pfizer Transthyretin Amyloidosis (ATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Corino Therapeutics Corporate Information, Location and Competitors
Table 12. Corino Therapeutics Transthyretin Amyloidosis (ATTR) Major Business
Table 13. Corino Therapeutics Transthyretin Amyloidosis (ATTR) Total Revenue (USD Million) (2018-2019)
Table 14. Corino Therapeutics SWOT Analysis
Table 15. Corino Therapeutics Transthyretin Amyloidosis (ATTR) Product and Solutions
Table 16. Corino Therapeutics Transthyretin Amyloidosis (ATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Alnylam Pharmaceuticals Corporate Information, Location and Competitors
Table 18. Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Major Business
Table 19. Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Total Revenue (USD Million) (2017-2018)
Table 20. Alnylam Pharmaceuticals SWOT Analysis
Table 21. Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product and Solutions
Table 22. Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Ionis Pharmaceuticals Corporate Information, Location and Competitors
Table 24. Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Major Business
Table 25. Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Total Revenue (USD Million) (2017-2018)
Table 26. Ionis Pharmaceuticals SWOT Analysis
Table 27. Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product and Solutions
Table 28. Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Arcturus Therapeutics Corporate Information, Location and Competitors
Table 30. Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Major Business
Table 31. Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Total Revenue (USD Million) (2017-2018)
Table 32. Arcturus Therapeutics SWOT Analysis
Table 33. Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Product and Solutions
Table 34. Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Proclara Bioscience Corporate Information, Location and Competitors
Table 36. Proclara Bioscience Transthyretin Amyloidosis (ATTR) Major Business
Table 37. Proclara Bioscience Transthyretin Amyloidosis (ATTR) Total Revenue (USD Million) (2017-2018)
Table 38. Proclara Bioscience SWOT Analysis
Table 39. Proclara Bioscience Transthyretin Amyloidosis (ATTR) Product and Solutions
Table 40. Proclara Bioscience Transthyretin Amyloidosis (ATTR) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Players (2015-2020)
Table 42. Global Transthyretin Amyloidosis (ATTR) Revenue Share by Players (2015-2020)
Table 43. Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Regions (2015-2020)
Table 45. North America Transthyretin Amyloidosis (ATTR) Revenue by Countries (2015-2020)
Table 46. North America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2015-2020)
Table 47. Europe Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Transthyretin Amyloidosis (ATTR) Revenue by Countries (2015-2020)
Table 50. South America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2015-2020)
Table 53. Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Type (2015-2020)
Table 54. Global Transthyretin Amyloidosis (ATTR) Revenue Share by Type (2015-2020)
Table 55. Global Transthyretin Amyloidosis (ATTR) Revenue Forecast by Type (2021-2025)
Table 56. Global Transthyretin Amyloidosis (ATTR) Revenue by Application (2015-2020)
Table 57. Global Transthyretin Amyloidosis (ATTR) Revenue Share by Application (2015-2020)
Table 58. Global Transthyretin Amyloidosis (ATTR) Revenue Forecast by Application (2021-2025)
Table 59. Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Transthyretin Amyloidosis (ATTR) Picture
Figure 2. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Type in 2019
Figure 3. Hereditary ATTR (HATTR) Picture
Figure 4. Wild-Type (WT) ATTR Picture
Figure 5. Transthyretin Amyloidosis (ATTR) Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Ambulatory Surgical Centers Picture
Figure 8. Diagnostic Centers Picture
Figure 9. Global Transthyretin Amyloidosis (ATTR) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Transthyretin Amyloidosis (ATTR) Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Transthyretin Amyloidosis (ATTR) Revenue Market Share in 2019
Figure 18. Global Top 10 Players Transthyretin Amyloidosis (ATTR) Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Regions (2015-2020)
Figure 22. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Regions in 2018
Figure 23. North America Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 24. Europe Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 26. South America Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 28. North America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2015-2020)
Figure 29. North America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries in 2019
Figure 30. USA Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 31. Canada Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 33. Europe Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries in 2019
Figure 35. Germany Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 36. UK Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 37. France Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 38. Russia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 39. Italy Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries in 2019
Figure 42. China Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 43. Japan Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 44. Korea Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 45. India Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 47. South America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2015-2020)
Figure 48. South America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries in 2019
Figure 49. Brazil Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 54. UAE Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2015-2020)
Figure 57. Global Transthyretin Amyloidosis (ATTR) Revenue Share by Type (2015-2020)
Figure 58. Global Transthyretin Amyloidosis (ATTR) Revenue Share by Type in 2019
Figure 59. Global Transthyretin Amyloidosis (ATTR) Market Share Forecast by Type (2021-2025)
Figure 60. Global Hereditary ATTR (HATTR) Revenue Growth Rate (2015-2020)
Figure 61. Global Wild-Type (WT) ATTR Revenue Growth Rate (2015-2020)
Figure 62. Global Transthyretin Amyloidosis (ATTR) Revenue Share by Application (2015-2020)
Figure 63. Global Transthyretin Amyloidosis (ATTR) Revenue Share by Application in 2019
Figure 64. Global Transthyretin Amyloidosis (ATTR) Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 66. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 67. Global Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 68. Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2021-2025)
Figure 72. Europe Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2021-2025)
Figure 74. South America Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---